You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 31, 2025

Details for Patent: 11,684,632


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,684,632 protect, and when does it expire?

Patent 11,684,632 protects LIVTENCITY and is included in one NDA.

Summary for Patent: 11,684,632
Title:Maribavir isomers, compositions, methods of making and methods of using
Abstract:The invention relates to novel compositions and methods of using maribavir which enhance its effectiveness in medical therapy, as well as to maribavir isomers and methods of use thereof for counteracting the potentially adverse effects of maribavir isomerization in vivo in the event it occurs.
Inventor(s):John D. Peabody, III
Assignee:Takeda Pharmaceutical Co Ltd
Application Number:US16/983,310
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 11,684,632: A Detailed Analysis

Introduction to Patent Analysis

When analyzing a patent, it is crucial to understand the scope and claims, as these elements define the invention's boundaries and the rights granted to the patent holder. This article will delve into the specifics of United States Patent 11,684,632, exploring its claims, the patent landscape, and relevant legal and technical aspects.

Identifying the Patent

United States Patent 11,684,632 is a utility patent granted by the United States Patent and Trademark Office (USPTO). The patent number, 11,684,632, is a unique identifier assigned to this granted patent, and the kind code B2 indicates that this is a utility patent for which an application was previously published[5].

Parts of a Patent

A patent document typically includes several key sections:

  • Abstract: A brief summary of the invention.
  • Background of the Invention: Context and prior art related to the invention.
  • Summary of the Invention: A concise description of the invention.
  • Detailed Description of the Invention: An in-depth explanation of the invention, including drawings and examples.
  • Claims: The most critical part, as they define the scope of the invention and the rights granted to the patent holder[5].

Understanding Patent Claims

Patent claims are the legal definitions of the invention and are crucial for determining the scope of protection. Here are some key points about patent claims:

Types of Claims

  • Independent Claims: These claims stand alone and do not depend on other claims. They define the broadest scope of the invention.
  • Dependent Claims: These claims refer back to and further limit an independent claim. They narrow down the scope of the invention[5].

Claim Language and Scope

The language used in patent claims is precise and technical. The scope of a patent is often measured by metrics such as independent claim length and independent claim count. Broader claims can be more challenging to enforce and may face higher scrutiny during the examination process. Narrower claims, while more specific, may offer stronger protection but with a limited scope[3].

The Case of United States Patent 11,684,632

To analyze the scope and claims of this specific patent, one must review the patent document itself. Here are some general steps and considerations:

Reviewing the Claims

  • Identify the independent and dependent claims.
  • Analyze the language and specificity of each claim.
  • Determine how the claims relate to the invention described in the detailed description and summary sections.

Legal Context

The listing of patents in the Orange Book, as seen in cases like Teva Branded Pharmaceutical Products R&D, Inc. v. Amneal, highlights the importance of ensuring that patents claim the actual drug or method of use. Patents that do not claim the drug itself but rather components or methods related to the drug can be subject to delisting if they do not meet the statutory requirements[1].

Patent Landscape and Competition

Generic Competition

In the pharmaceutical industry, the timing of patent expiration and the approval of generic drugs are critical. The Hatch-Waxman Act and subsequent amendments like the Orange Book Transparency Act aim to balance the rights of brand-name manufacturers with the need for generic competition. Patents that delay generic entry can significantly impact market dynamics and consumer access to affordable medications[1].

Patent Scope and Innovation

The scope of a patent can influence innovation. Broader patents may stifle innovation by creating barriers to entry for other inventors, while narrower patents may encourage further development by allowing more room for improvement and variation. The quality and scope of patents are ongoing topics of debate, with metrics like independent claim length and count being used to assess patent quality[3].

Natural Language Processing in Patent Analysis

Natural Language Processing (NLP) is increasingly used in patent analysis to parse and understand the complex language of patent claims. NLP can help in identifying dependencies between claims, measuring patent scope, and assessing the novelty and non-obviousness of inventions. This technology can streamline the patent examination process and provide more accurate assessments of patent validity[4].

Key Takeaways

  • Patent Claims: The claims section is the most critical part of a patent, defining the scope of protection.
  • Claim Language: The specificity and breadth of claim language can significantly impact the enforceability and scope of the patent.
  • Legal Context: Patents must comply with statutory requirements, such as those outlined in the Hatch-Waxman Act and the Orange Book Transparency Act.
  • Patent Landscape: The scope of a patent can influence competition, innovation, and market dynamics.
  • NLP in Patents: Natural Language Processing can enhance the analysis and examination of patent claims.

FAQs

What is the significance of the claims section in a patent?

The claims section defines the legal boundaries of the invention and the rights granted to the patent holder.

How do independent and dependent claims differ?

Independent claims stand alone and define the broadest scope of the invention, while dependent claims further limit an independent claim and narrow down the scope.

What is the Orange Book Transparency Act, and how does it impact patent listings?

The Orange Book Transparency Act aims to prevent brand-name manufacturers from listing patents that do not claim the actual drug or method of use, thereby preventing the delay of generic drug approvals.

How does Natural Language Processing (NLP) aid in patent analysis?

NLP helps in parsing and understanding patent claims, identifying dependencies, measuring patent scope, and assessing novelty and non-obviousness.

What metrics are used to measure patent scope?

Metrics such as independent claim length and independent claim count are used to measure patent scope and assess patent quality.

Sources

  1. Teva Branded Pharmaceutical Products R&D, Inc. v. Amneal, CAFC, December 20, 2024.
  2. Patent Claims Research Dataset, USPTO, August 28, 2017.
  3. Patent Claims and Patent Scope, SSRN, September 29, 2016.
  4. Natural Language Processing in Patents: A Survey, arXiv, August 12, 2024.
  5. Parts of a Patent, UW-Madison Libraries.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,684,632

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
Takeda Pharms Usa LIVTENCITY maribavir TABLET;ORAL 215596-001 Nov 23, 2021 RX Yes Yes ⤷  Try for Free ⤷  Try for Free TREATMENT OF PATIENTS WITH POST-TRANSPLANT CYTOMEGALOVIRUS (CMV) INFECTION/DISEASE REFRACTORY TO TREATMENT WITH GANCICLOVIR, VALGANCICLOVIR, CIDOFOVIR, OR FOSCARNET, WHERE THE PATIENT IS A STEM CELL, KIDNEY, OR LIVER TRANSPLANT RECIPIENT ⤷  Try for Free
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 1 to 1 of 1 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.